MERSILENE POLYESTER FIBER SUTURE UNKNOWN PRODUCT MERSSUTUNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,l report with the FDA on 2020-03-18 for MERSILENE POLYESTER FIBER SUTURE UNKNOWN PRODUCT MERSSUTUNK manufactured by Ethicon Inc..

Event Text Entries

[188987587] Product complaint # (b)(4). This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided. The single complaint was reported with multiple events. There are no additional details regarding the additional events. Citation: the journal of maternal-fetal & neonatal medicine, doi: 10. 1080/14767058. 2019. 1702960. Attempts are being made to obtain the following information. To date no response has been provided. If further details are received at a later date a supplemental medwatch will be sent. Does the surgeon believe that ethicon products (mersilene suture) involved caused and/or contributed to the post-operative complications described in the article? Does the surgeon believe there was any deficiency with the ethicon products (mersilene suture) used in this procedure? Were the cases discussed in this article previously reported to ethicon? Patient demographics (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[188987588] It was reported in a journal article with title: emergency cerclage following a standardized protocol offers an effective and safe therapeutic option for omen with high risk for prematurity? A retrospective monocentric cohort study on 130 pregnancies and 155 neonates. The aim of this case study is to demonstrate emergency cerclages (ecs) as a safe and effective therapeutic option to prevent severe prematurity or threatening miscarriage in midtrimester cervical insufficiency when treated by standardized protocol. This retrospective monocentric cohort study involving 130 pregnancies (105 single and 25 twin pregnancies) who underwent cerclage placements between july 2007 and june 2018. The majority of interventions were performed by mcdonald-type cerclages. Only patients with an intravaginal part of the cervix being less than 5mm were treated with a shirodka-type ec. A single purse-string suture with 5mm mersilene polyester bp-2 (40-mm length) (ethicon) was used. Reported complication included amnion-infection syndrome (n-12), septicemia (n-1), and early-onset neonatal sepsis related to cerclage (n-17) ec represent a safe and effective therapeutic option for preventing extreme premature birth in pregnancies with advanced midtrimester cervical dilation.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2210968-2020-02223
MDR Report Key9851289
Report SourceFOREIGN,HEALTH PROFESSIONAL,L
Date Received2020-03-18
Date of Report2020-02-24
Date Mfgr Received2020-02-24
Date Added to Maude2020-03-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKARA DITTY-BOVARD
Manufacturer StreetP.O. BOX 151, ROUTE 22 WEST
Manufacturer CitySOMERVILLE NJ 08876
Manufacturer CountryUS
Manufacturer Postal08876
Manufacturer Phone6107428552
Manufacturer G1ETHICON INC.
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMERSILENE POLYESTER FIBER SUTURE UNKNOWN PRODUCT
Generic NameSUTURE, NONABSORBABLE, SYNTHETIC
Product CodeGAT
Date Received2020-03-18
Catalog NumberMERSSUTUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerETHICON INC.
Manufacturer AddressP.O. BOX 151, ROUTE 22 WEST SOMERVILLE NJ 08876 US 08876


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.